在维吾尔族DLBCL中,TP53突变的低发病率和早期复发率的降低之间存在关联

Mutibaier Mijiti1, Chun Wang1, Wenxin Tian1

  • 1Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, No. 91, Tianchi Road, Urumqi, 830011, Xinjiang Uygur Autonomous Region, China.

Annals of hematology
|August 26, 2024
PubMed
概括

患有扩散性大B细胞淋巴瘤 (DLBCL) 的中国维吾尔族患者由于TP53突变率较低,预后更好. 与汉族患者相比,这种遗传差异有助于降低他们的复发风险.